PACB R&D Expenses
Pacific Biosciences Of California · R&D Expenses
PACB R&D Expenses
Latest reported$23.02Mperiod ending
PACB Quarterly R&D Expenses ($21.12M → $23.02M)
Quarterly R&D Expenses
High-resolution chart · PNG
PACB r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 23,022,000 | |
| 19,608,000 | |
| 22,879,000 | |
| 22,846,000 | |
| 22,529,000 | |
| 29,053,000 | |
| 27,466,000 | |
| 25,516,000 | |
| 38,485,000 | |
| 43,455,000 | |
| 44,544,000 | |
| 47,514,000 | |
| 46,173,000 | |
| 48,939,000 | |
| 42,623,000 | |
| 47,092,000 | |
| 50,348,000 | |
| 52,937,000 | |
| 42,576,000 | |
| 27,508,000 | |
| 22,266,000 | |
| 20,548,000 | |
| 17,425,000 | |
| 16,467,000 | |
| 15,010,000 | |
| 15,250,000 | |
| 14,273,000 | |
| 14,962,000 | |
| 14,910,000 | |
| 15,485,000 | |
| 16,263,000 | |
| 14,356,000 | |
| 15,664,000 | |
| 16,311,000 | |
| 15,626,000 | |
| 15,844,000 | |
| 16,883,000 | |
| 16,971,000 | |
| 16,255,000 | |
| 17,479,000 | |
| 17,522,000 | |
| 16,361,000 | |
| 14,752,000 | |
| 16,162,000 | |
| 15,043,000 | |
| 14,483,000 | |
| 12,331,000 | |
| 11,693,000 | |
| 12,435,000 | |
| 11,771,000 | |
| 11,133,000 | |
| 10,419,000 | |
| 11,682,000 | |
| 11,983,000 | |
| 11,652,000 | |
| 12,626,000 | |
| 11,272,000 | |
| 12,073,000 | |
| 12,415,000 | |
| 20,001,000 | |
| 19,546,000 | |
| 24,118,000 | |
| 26,542,000 | |
| 32,873,000 | |
| 27,082,000 | |
| 25,324,000 | |
| 24,668,000 | |
| 21,121,000 |